Journals / Türk Biyokimya Dergisi / 2014 / Cilt: 39 - Sayı: 3

Asymmetric dimethylarginine levels in Behçet’s disease

[Behçet hastalarında asimetrik dimetilarginin düzeyleri]

Pages
362–367
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Our study suggests that the reduced levels of ADMA in patients group may impose a possible preventive role to ADMA through decrease of NO-mediated inflammation and exacerbations of BD with aging

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Behçet's disease (BD) is a chronic, inflammatory, multisystem vasculitis and the etiology is not yet fully understood.
📊
Key Findings & Data:Therefore, we aimed to investigate levels of the ADMA and its relation with exacerbations in BD patients.Methods: The subjects enrolled in this study were recruited from 34 patients with BD and 34 healthy controls.
💡
Conclusion & Impact:Our study suggests that the reduced levels of ADMA in patients group may impose a possible preventive role to ADMA through decrease of NO-mediated inflammation and exacerbations of BD with aging
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Behçet's disease (BD) is a chronic, inflammatory, multisystem vasculitis and the etiology is not yet fully understood. Nitric Oxide (NO) is an important molecule for the vascular system which synthesised by the Nitric Oxide Synthase (NOS) enzyme. Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of NOS. Therefore, we aimed to investigate levels of the ADMA and its relation with exacerbations in BD patients.Methods: The subjects enrolled in this study were recruited from 34 patients with BD and 34 healthy controls. Serum levels of ADMA, arginine and citrulline were measured by HPLC with fluorescence detection. The ESR and CRP levels analyzed by routinely used methods.Results: In contrast to information in the literature, ADMA levels were found to be decreased in BD patients when compared to control. Inversely, Arginine and Citrulline levels were significantly increased in BD patients. Increased Arginine/ADMA ratios were found in the patient group. There was an inverse relation between ADMA and CRP levels. Arginine values were also correlated CRP and Citrulline levels.Conclusion: One of the reasons of high number of BD attacks in young age may be low levels of ADMA. Our study suggests that the reduced levels of ADMA in patients group may impose a possible preventive role to ADMA through decrease of NO-mediated inflammation and exacerbations of BD with aging

Özet

Amaç: Behçet Hastalığı (BH), etiyolojisi tam olarak anlaşılmamış, kronik, inflamatuvar multisistemik bir vaskülittir. Nitrik Oksit (NO), endotel hücrelerinde Nitrik Oksit Sentaz (NOS) enzimi tarafından sentezlenen, vasküler sistem için önemi olan bir moleküldür. Asimetrik dimetilarjinin (ADMA) NOS'ın endojen inhibitörüdür. Bu çalışmada BH'larında ADMA düzeyleri ve ataklarla ilgisinin araştırılması amaçlandı.Metod: 34 Behçet hastası ve 34 sağlıklı kontrol çalışmaya dâhil edildi. Serum ADMA, arjinin ve sitrülin düzeyleri HPLC yöntemi ile saptandı. ESR ve CRP düzeyleri rutin yöntemlerle analiz edildi.Bulgular: Literatür bilgilerine ters olarak Behçet hastalarında ADMA düzeyleri kontrol grubuna göre düşük bulundu. Bunun aksine Arjinin ve Sitrülin düzeyleri Behçet hastalarında anlamlı derecede yüksek bulundu. Hasta grubunda Arjinin/ADMA oranları yüksek bulundu. ADMA ve CRP düzeyleri arasında ters bir korelasyon vardı. Arjinin değerleri de sitrülin ve CRP düzeyleri ile koreleydi. Sonuç: BH da genç yaşta atakların sayısının fazla olmasının sebeblerinden birisi düşük ADMA düzeyleri olabilir. Bizim çalışmamız hasta grubundaki düşük ADMA düzeylerine, yaşlanma ile BH alevlenmelerini ve NO aracılıklı inflamasyonu azaltması nedeniyle muhtemel önleyici bir rol yüklemektedir

🔖

Cite This Article

VATANSEV, H., ÖZTÜRK, B., YILMAZ, S., DAĞLI, M., TANER, A., ÜNLÜ, A. (2022). Asymmetric dimethylarginine levels in Behçet’s disease. Türk Biyokimya Dergisi, Cilt: 39 - Sayı: 3, 362–367. https://ajindex.com/articles/621233

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Behcet H. Uber rezidivierende Apthose, durch ein Virus verursachte geschwure am Mund, am Auge und an den Genitalien. Dermatol Wochenschr 1937; 105:1152-7
  2. Pandrea A, Rudinskaya A, Klein B, Krebs T. What does it take to diagnose Behcet disease? J Clin Rheumatol 2007; 13:31-4
  3. Evereklioğlu C. Current concepts in the etiology and treatment of Behçet disease. Surv Ophthalmol 2005; 50(4):297-350
  4. Aytugar E, Pekiner FN. Behçet’s disease, Journal of Marmara University Institute of Health Sciences 2011; 1(1):63-73
  5. Sahin M, Arslan C, Naziroglu M, Tunc SE, Demirci M, et al. Asymmetric dimethylarginine and nitric oxide levels as signs of endothelial dysfunction in Behcet’s disease. Ann Clin Lab Sci 2006; 36(4):449-54
  6. Ozturk MA, Oktar SO, Unverdi S, Ureten K, Goker B, et al. Morphologic evidence of subclinical atherosclerosis obtained by carotid ultrasonography in patients with Behcet’s disease. Rheumatol Int 2006; 26:867-72
  7. Lowenstein CJ, Dinerman JL, Synder SH. Nitric Oxide: A Physiologic Messenger. Annals of Internal Medicine 1994; 120(3):227- 37
  8. Billiar TR. Nitric Oxide, Novel biolgy with Clinical Relevance. Annals of Surgery 1995; 221(4):339-49
  9. Forstermann U, Closs EI, Pollock JS, Nakane M, Schwarz P, et al. Nitric Oxide Synthase Isozymes. Hypertension 1994; 23(6):1121- 31
  10. Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339:572-5
  11. Erbil MK, Kurt YG, Yaman H, Cakir E, Akgul EO, et al. Metabolism of asymmetric dimethylarginine and its clinical significance. Turk J Biochem. 2012; 37(1);99-105
  12. Southan GJ, Szabo C. Selective Pharmalogical Inhibition of Distinct NOS Isoforms. Biochem Pharma 1996: 51;383-94
  13. Ogawa T, Kimoto M, Sasaoka K. Purification and properties of a new enzyme. NG, NG-dimethylarginine dimethylaminohydrolase from rat kidney. The Journal of Biological Chemistry 1989; 264(17):10205-9
  14. Kimoto M, Whitley GS, Tsuji H, Ogawa T. Detection of NG, NGdimethylarginine dimethylaminohydrolase in human tissues using a monoclonal antibody. J Biochem 1995; 117:237-8
  15. Melikoglu M, Topkarci Z. Is there a relation between clinical disease activity and acute phase response in Behcet’s disease? International Journal of Dermatology 2014; 53:250-4
  16. Criteria for diagnosis of Behçet’s disease. International Study Group for Behçet’s Disease. Lancet 1990; 335(8697):1078-80
  17. Taner A, Unlu